Literature DB >> 18946365

Experience using peripherally inserted central venous catheters for outpatient parenteral antibiotic therapy in children at a community hospital.

Patrick Van Winkle1, Teri Whiffen, In-Lu Amy Liu.   

Abstract

BACKGROUND: Outpatient parenteral antibiotic therapy with peripherally inserted central catheters (PICCs) is safe, clinically effective, and cost effective in pediatric populations cared for at academic and free-standing pediatric hospitals. Our study evaluates the transferability of these findings to a community hospital setting.
METHODS: Data were retrospectively collected on PICCs used in children at a community hospital from December 2003 to September 2006. The Fisher exact test and a logistic regression were used for statistical analysis.
RESULTS: Thirty-nine PICCs were placed in 34 patients. The total number of catheter days at home was 800 (mean 20.5 +/- 13.9). We demonstrated a 97% success rate in completing therapy at home, with 82.3% completion with a single PICC. Our overall complication rate was 33.3%, consisting of occlusion, accidental displacement, cracks in the catheters, and local irritation. There were no instances of phlebitis or suspected or confirmed catheter infection or sepsis. There were no statistically significant differences in these values compared with reports from major pediatric centers. The cost savings was $1070 per day of home health care when compared with costs of inpatient hospitalization.
CONCLUSIONS: We believe that this is the first study to demonstrate the effectiveness of PICC use for outpatient parenteral antibiotic therapy in pediatric patients in a community hospital setting, and demonstrates the ability for this to be done at the standard of care expected at major pediatric centers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946365     DOI: 10.1097/INF.0b013e31817d32f2

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Frequency of peripherally inserted central catheter complications in children.

Authors:  Angela Barrier; Derek J Williams; Megan Connelly; C Buddy Creech
Journal:  Pediatr Infect Dis J       Date:  2012-05       Impact factor: 2.129

2.  Comparison of complications between pediatric peripherally inserted central catheter placement techniques.

Authors:  Niloy Dasgupta; Manish N Patel; John M Racadio; Neil D Johnson; Matthew P Lungren
Journal:  Pediatr Radiol       Date:  2016-04-28

Review 3.  Quality and Safety of Pediatric Inpatient Care in Community Hospitals: A Scoping Review.

Authors:  Jana C Leary; Kathleen E Walsh; Rebecca A Morin; Elisabeth G Schainker; JoAnna K Leyenaar
Journal:  J Hosp Med       Date:  2019-09-18       Impact factor: 2.960

4.  Being 'at-home' on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents' experiences of paediatric OPAT.

Authors:  Bernie Carter; Debra Fisher-Smith; David Porter; Steven Lane; Matthew Peak; David Taylor-Robinson; Louise Bracken; Enitan Carrol
Journal:  Arch Dis Child       Date:  2019-09-26       Impact factor: 3.791

Review 5.  Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.

Authors:  Ann L N Chapman; Sanjay Patel; Carolyne Horner; Helen Green; Achyut Guleri; Sara Hedderwick; Susan Snape; Julie Statham; Elizabeth Wilson; Mark Gilchrist; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2019-08-26

6.  Delivery, setting and outcomes of paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): a scoping review.

Authors:  Bernie Carter; Enitan D Carrol; David Porter; Matthew Peak; David Taylor-Robinson; Debra Fisher-Smith; Lucy Blake
Journal:  BMJ Open       Date:  2018-11-15       Impact factor: 2.692

7.  Paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): An e-survey of the experiences of parents and clinicians.

Authors:  Bernie Carter; Debra Fisher-Smith; David Porter; Steven Lane; Matthew Peak; David Taylor-Robinson; Louise Bracken; Enitan D Carrol
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.